First India-made mRNA-based booster vaccine for Omicron announced
The Pune-based Gennova Biopharmaceuticals has announced it is ready to launch the first made-in-India mRNA-based COVID-19 Omicron virus subtype-specific booster vaccine, called GEMCOVAC-OM.
Gennova Biopharmaceuticals has become the first Indian company to get the approval of the Drugs Controller General of India (DGCI) for an mRNA-based Omicron-specific booster vaccine. It has received DGCI’s emergency use authorisation (EUA) certificate, the company says on its website.
The booster vaccine for COVID-19 is called GEMCOVAC-OM.
The vaccine has “demonstrated robust immune responses in phase 3 clinical trials conducted at 20 centres across 13 cities,” said Dr Sanjay Singh, CEO of the Pune-based company.
“The vaccine is safe and well-tolerated and could prevent future waves of the pandemic,” he added.
As per company sources, 12 lakh doses are presently available. The launch is expected within two to three weeks in New Delhi, when details on the cost and other aspects will be announced.
